Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

  • Christopher S. Koivisto
  • , Melodie Parrish
  • , Santosh B. Bonala
  • , Soo Ngoi
  • , Adrian Torres
  • , James Gallagher
  • , Rebekah Sanchez-Hodge
  • , Victor Zeinner
  • , Georges J. Nahhas
  • , Bei Liu
  • , David E. Cohn
  • , Floor J. Backes
  • , Paul J. Goodfellow
  • , Helen M. Chamberlin
  • , Gustavo Leone

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)484-496
Number of pages13
JournalNeoplasia (United States)
Volume22
Issue number10
DOIs
StatePublished - Oct 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Cancer Research

Keywords

  • Androgen receptor antagonist
  • Endometrial carcinoma
  • Enzalutamide
  • Mouse model of endometrial cancer
  • PTEN
  • Preclinical drug evaluation

Cite this